Searched for
AUTOIMMUNE DISEASE TRIALS
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- Could space-grown stem cells unlock faster cancer treatments and revolutionize organ regeneration breakthroughs? NASA’s ISS experiments are revealing surprising answers about the power of microgravity medicineSpace stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...
- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...
- US market today: Biotech firm Odyssey hits nearly $900 million valuation as shares rise in Nasdaq debutOdyssey Therapeutics debuted on Nasdaq with an 11.1% surge, reaching a $899.9 million valuation. The autoimmune disease specialist successf...
- Diabetes, rheumatoid arthritis, sclerosis, lupus be cured? Scientists are trying revolutionary approach to treat autoimmune diseasesWhen your body’s immune cells attack you instead of protecting you, today’s treatments tamp down the friendly fire but they don’t fix what’...
- Nobel Prize 2025 in Medicine awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi for discoveries in immune toleranceThe 2025 Nobel Prize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveri...
- AstraZeneca's asthma drug fails 'smoker's lung' studyAstraZeneca's Fasenra failed to reduce flare-ups in COPD patients in a late-stage trial, a setback for the company's efforts to address the...
- Drug deals: 8 doctors, 50+ pharma firms under microscope for unauthorised trials at Ahmedabad hospitalA preliminary inquiry revealed that eight doctors and an associate professor at V S Hospital in Ahmedabad allegedly collaborated with over ...
- Ahammune Biosciences raises $5 million to fund novel vitiligo therapyThe funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for vitiligo - an autoimm...
- First drug to treat hair loss disorder alopecia gets FDA approvalU.S. FDA has approved Eli Lilly's drug, Olumiant, which is considered the first to treat severe hair loss.
- Biocon Biologics says clinical study for drug Itolizumab initiated in India after approval from DCGIBiocon's partner US-based Equillium Inc has expanded its 'EQUALISE' study in Systemic Lupus Erythematosus (SLE) and Lupus Nephritis for Ito...
- Glenmark's subsidiary Ichnos Sciences enters pact with Almirall for novel drug to treat autoimmune diseasesUnder the agreement, Almirall is granted global rights to develop and commercialize this monoclonal antibody for autoimmune diseases. Ichno...
- Zydus gets nod to conduct Phase II clinical study in patients with CAPS in AustraliaCAPS is a rare life-long auto-inflammatory condition, and is classified under orphan diseases. CAPS patients also experience multiple neuro...
- Yoga can be used as adjunct therapy in inflammatory rheumatoid arthritis management: StudyThe results of the study suggested that there was a decrease in disease activity after yoga.
- US begins stockpiling malaria medicine for treating COVID-19 patientsThe US has started procuring malaria medicine 'Hydroxychloroquine' for treating COVID-19 patients as it anticipates a favourable result fro...
- Watch what you eat! Bacteria in undercooked chicken may lead to paralysisA common bacterium found in improperly cooked chicken can cause Guillain-Barre Syndrome - the leading cause of acute neuromuscular paralysi...
- Bacterium in undercooked chicken causes paralysis: StudyNew York, Dec 11 (IANS) US researchers have identified a bacterium, commonly found in undercooked chicken, that may cause Guillain-Barre Sy...
- Glenmark Pharmaceuticals completes phase I clinical trials for antibodyGlenmark Pharmaceuticals has completed the clinical phase I studies for its novel monoclonal antibody 'GBR 830' for treating autoimmune dis...
- Glenmark Pharmaceuticals' new molecule enters human trialsGlenmark Pharmaceuticals S.A., a wholly owned Swiss subsidiary of Glenmark Pharmaceuticals, said GBR 830 is entering human trials.
Load More
